NEW YORK, Feb. 7, 2017 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Kitov Pharmaceutical Holdings LTD ("Kitov" or the "Company") (NASDAQ: KTOV). Such investors can obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ktov.
The investigation concerns whether Kitov and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On February 6, 2017, Calcalist, an Israeli publication, reported that Kitov's CEO Isaac Israel had been detained and questioned by the Israeli Securities Authority for allegedly publishing misleading information about Kitov's recent clinical trial. Following this news, Kitov stock dropped $0.33 per share, or 11.46%, to close at $2.55 on February 6, 2017.
If you are aware of any facts relating to this investigation, or purchased Kitov shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/ktov. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-kitov-pharmaceutical-holdings-ltd-ktov-300403241.html
SOURCE Bronstein, Gewirtz & Grossman, LLC